These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20097486)

  • 21. Brachytherapy for prostate cancer does not influence long-term depression rate.
    Jongkamp VG; Roeloffzen EM; Monninkhof EM; de Leeuw JR; Lycklama à Nijeholt AA; van Vulpen M
    Brachytherapy; 2012; 11(6):495-501. PubMed ID: 22459065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
    Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer.
    Ash D; Bottomley D; Al-Qaisieh B; Carey B; Gould K; Henry A
    Radiother Oncol; 2007 Aug; 84(2):135-9. PubMed ID: 17604140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline health-related quality of life in the management of prostate cancer.
    Ishihara M; Suzuki H; Akakura K; Komiya A; Imamoto T; Tobe T; Ichikawa T
    Int J Urol; 2006 Jul; 13(7):920-5. PubMed ID: 16882056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.
    Kenny PM; King MT; Viney RC; Boyer MJ; Pollicino CA; McLean JM; Fulham MJ; McCaughan BC
    J Clin Oncol; 2008 Jan; 26(2):233-41. PubMed ID: 18086802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
    Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy.
    Staff I; Salner A; Bohannon R; Panatieri P; Maljanian R
    Cancer; 2003 Dec; 98(11):2335-43. PubMed ID: 14635067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
    Jayadevappa R; Bloom BS; Chhatre S; Fomberstein KM; Wein AJ; Malkowicz SB
    J Urol; 2005 Sep; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey.
    Vordermark D; Wulf J; Markert K; Baier K; Kölbl O; Beckmann G; Bratengeier K; Noe M; Schön G; Flentje M
    Acta Oncol; 2006; 45(6):708-16. PubMed ID: 16938814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36).
    Ficarra V; Novara G; Galfano A; Stringari C; Baldassarre R; Cavalleri S; Artibani W
    BJU Int; 2006 Feb; 97(2):274-8. PubMed ID: 16430628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer.
    Caffo O; Fellin G; Bolner A; Coccarelli F; Divan C; Frisinghelli M; Mussari S; Ziglio F; Malossini G; Tomio L; Galligioni E
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):31-7. PubMed ID: 16765529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional analysis of sexual function after prostate brachytherapy.
    Finney G; Haynes AM; Cross P; Brenner P; Boyn A; Stricker P
    Urology; 2005 Aug; 66(2):377-81. PubMed ID: 16098365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
    Wahlgren T; Levitt S; Kowalski J; Nilsson S; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):997-1004. PubMed ID: 20932681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Wust P; von Borczyskowski DW; Henkel T; Rosner C; Graf R; Tilly W; Budach V; Felix R; Kahmann F
    Radiother Oncol; 2004 Oct; 73(1):39-48. PubMed ID: 15465144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term rectal function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
    Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.